BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 8395957)

  • 21. Direct evidence for the up-regulation of spinal micro-opioid receptor function after repeated stimulation of kappa-opioid receptors in the mouse.
    Narita M; Khotib J; Mizoguchi H; Suzuki M; Ozaki S; Yajima Y; Tseng LF; Suzuki T
    Eur J Neurosci; 2003 Nov; 18(9):2498-504. PubMed ID: 14622150
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cross-tolerance to acute administration of mu and kappa opioid agonists at the spinal cord level in the rat.
    Laurido C; Hernandez A; Perez H
    Int J Neurosci; 1996 Nov; 87(3-4):191-9. PubMed ID: 9003979
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mu antagonist properties of kappa agonists in a model of rat urinary bladder motility in vivo.
    Sheldon RJ; Nunan L; Porreca F
    J Pharmacol Exp Ther; 1987 Oct; 243(1):234-40. PubMed ID: 2822899
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of chronic administration of morphine, U-50, 488H and [D-Pen2, D-Pen5]enkephalin on the concentration of cGMP in brain regions and spinal cord of the mouse.
    Bhargava HN; Cao YJ
    Peptides; 1997; 18(10):1629-34. PubMed ID: 9437726
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Streptozotocin-induced diabetes selectively alters the potency of analgesia produced by mu-opioid agonists, but not by delta- and kappa-opioid agonists.
    Kamei J; Ohhashi Y; Aoki T; Kawasima N; Kasuya Y
    Brain Res; 1992 Feb; 571(2):199-203. PubMed ID: 1319265
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Brain and spinal cord kappa opiate receptors and pharmacological responses to U-50,488H in rats of differing ages.
    Bhargava HN; Matwyshyn GA; Reddy PL; Veeranna
    Pharmacol Biochem Behav; 1994 May; 48(1):87-91. PubMed ID: 8029307
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Enhancement of a kappa-opioid receptor agonist-induced analgesia by L-tyrosine and L-tryptophan.
    Barjavel MJ; Thorat SN; Bhargava HN
    Eur J Pharmacol; 1994 Jun; 258(3):173-8. PubMed ID: 8088353
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cross-tolerance between kappa and mu opioid agonists in the guinea pig ileum myenteric plexus.
    Garaulet JV; Milanés MV; Laorden ML
    J Pharmacol Exp Ther; 1995 Feb; 272(2):658-62. PubMed ID: 7853179
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of 7-nitroindazole on tolerance to morphine, U-50,488H and [D-Pen2, D-Pen5] enkephalin in mice.
    Bhargava HN; Cao YJ; Zhao GM
    Peptides; 1997; 18(6):797-800. PubMed ID: 9285927
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of spinal kappa opioid receptors in the blockade of the development of antinociceptive tolerance to morphine.
    Takahashi M; Senda T; Kaneto H
    Eur J Pharmacol; 1991 Aug; 200(2-3):293-7. PubMed ID: 1664330
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Roles of central and peripheral mu, delta and kappa opioid receptors in the mediation of gastric acid secretory effects in the rat.
    Fox DA; Burks TF
    J Pharmacol Exp Ther; 1988 Feb; 244(2):456-62. PubMed ID: 2831341
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of ibogaine on the development of tolerance to antinociceptive action of mu-, delta- and kappa-opioid receptor agonists in mice.
    Cao YJ; Bhargava HN
    Brain Res; 1997 Mar; 752(1-2):250-4. PubMed ID: 9106464
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The kappa opioid agonist U-50,488H antagonizes respiratory effects of mu opioid receptor agonists in conscious rats.
    Dosaka-Akita K; Tortella FC; Holaday JW; Long JB
    J Pharmacol Exp Ther; 1993 Feb; 264(2):631-7. PubMed ID: 8382278
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effect of U-50,488H tolerance-dependence and abstinence on the levels of dynorphin (1-13) in brain regions, spinal cord, pituitary gland and peripheral tissues of the rat.
    Bhargava HN; Matwyshyn GA; Rattan AK; Koo KL; Tejwani GA
    Brain Res; 1993 Jan; 600(1):151-5. PubMed ID: 8093675
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differential influence of D1 and D2 dopamine receptors on acute opiate withdrawal in guinea-pig isolated ileum.
    Capasso A; Sorrentino L
    Br J Pharmacol; 1997 Mar; 120(6):1001-6. PubMed ID: 9134209
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nitric oxide synthase inhibition blocks tolerance to the analgesic action of kappa-opiate receptor agonist in the rat.
    Bhargava HN
    Pharmacology; 1994 Apr; 48(4):234-41. PubMed ID: 7513892
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of dizocilpine (MK-801) on analgesia and tolerance induced by U-50,488H, a kappa-opioid receptor agonist, in the mouse.
    Bhargava HN; Thorat SN
    Brain Res; 1994 Jun; 649(1-2):111-6. PubMed ID: 7953621
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sufentanil, morphine, met-enkephalin, and kappa-agonist (U-50,488H) inhibit substance P release from primary sensory neurons: a model for presynaptic spinal opioid actions.
    Chang HM; Berde CB; Holz GG; Steward GF; Kream RM
    Anesthesiology; 1989 Apr; 70(4):672-7. PubMed ID: 2467589
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serotonergic involvement in the antinociceptive action of and the development of tolerance to the kappa-opioid receptor agonist, U-50, 488H.
    Ho BY; Takemori AE
    J Pharmacol Exp Ther; 1989 Aug; 250(2):508-14. PubMed ID: 2547935
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Modulation of kappa-opioid receptor mediated tolerance in the guinea-pig ileum by chronic co-administration of dihydropyridines.
    Garaulet JV; Laorden ML; Milanés MV
    Naunyn Schmiedebergs Arch Pharmacol; 1996 Jun; 354(1):72-9. PubMed ID: 8832591
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.